LINDEN LAKE STRATEGY

iStock-949947192.jpg

BUILDING

Building and seeding technologies and companies from the infancy stage to translate science into commercial reality.

iStock-494470400.jpg

INVESTING

Investing in world-class molecular medicine companies at an early stage with a clear pathway to an exit.

iStock-928173182.jpg

Founding

Identifying and combining transformative biotechnologies, brilliant scientific teams and intrepid executives to form best-in-class biotechnology companies.

We are focusing on the following investment opportunities:

Investment Sectors:

  • Drug Discovery (First-in-class or new biology-based approach)

  • Innovative Platform Technologies for Drug Discovery

  • Corporate Spin-out Opportunities

Therapeutic areas:

  • Oncology

  • Immunology

  • Hepatology

  • Cardiovascular/Respiratory

  • Neurology

  • Orphan Diseases

Modality:

  • Targeted Small Molecules

  • Biologics

  • Gene/Cell Therapy

Stage:

  • Research to Pre-IND

  • IND to Clinical Proof of Concept